Elder Pharmaceuticals slipped 1.58% to Rs 352 at 15:14 IST on BSE after the company said it has deferred plans of raising $50 million through issue of foreign currency convertible bonds/global depository receipts.
The stock hit a high of Rs 356 and a low of Rs 332 so far during the day. The stock had a 52-week high of Rs 470 on
The company’s current equity is Rs 631.56 crore. Face value per share is Rs 10.
The current price of Rs 356 discounts its Q3 December 2007 annualized EPS of Rs 40.68, by a PE multiple of 8.75.
The company has deferred its propoposed foreign currency convertible bonds (FCCB) issue due to uncertainties in the international markets.
Elder Pharmaceuticals’ net profit rose 30.7% to Rs 19.04 crore on 19.9% growth in net sales to Rs 138.78 crore in Q3 December 2007 over Q3 December 2006.
The company is engaged in manufacturing and marketing pharmaceutical products.
No comments:
Post a Comment